Zhifei Cao

Dr. Zhifei Cao

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2017 in RNA
Verified
Journal Article
Open access
PDF file
WLWenming Liu
Wenming Liu
CLChunping Lv
Chunping Lv
BZBin Zhang
Bin Zhang
QZQuansheng Zhou
Quansheng Zhou
ZCZhifei Cao
Zhifei Cao
Aggressive cancer cells gain robust tumor vascular mimicry (VM) capability that promotes tumor growth and metastasis. VE-cadherin is aberrantly overexpressed in vasculogenic cancer cells and regarded as a master gene of tumor VM. Although microRNAs (miRNAs) play an important role in modulating tumor angiogenesis and cancer metastasis, the miRNA that targets VE-cadherin expression in cancer cells to inhibit tumor cell-mediated VM is enigmatic. In this study, we found that miR-27b levels are negatively co-related to VE-cadherin expression in ovarian cancer cells and tumor cell-mediated VM, and demonstrated that miR-27b could bind to the 3′-untranslated region (3′UTR) of VE-cadherin mRNA. Overexpression of miR-27b in aggressive ovarian cancer cell lines Hey1B and ES2 significantly diminished intracellular VE-cadherin expression; convincingly, the inhibitory effect of miR-27b could be reversed by miR-27b specific inhibitor. Intriguingly, miR-27b not only effectively suppressed ovarian cancer cell migration and invasion, but also markedly inhibited formation of ovarian cancer cell-mediated capillary-like structures in vitro and suppressed generation of functional tumor blood vessels in mice. Together, our study suggests that miR-27b functions as a new inhibitor of ovarian cancer cell-mediated VM through suppression of VE-cadherin expression, providing a new potential drug candidate for antitumor VM and anti-ovarian cancer therapy.

1 January 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
HHHongyan Han
Hongyan Han
LDLongsheng Du
Longsheng Du
ZCZhifei Cao
Zhifei Cao
BZBin Zhang
Bin Zhang
QZQuansheng Zhou
Quansheng Zhou

6 March 2020 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
BYBo Yang
Bo Yang
BZBin Zhang
Bin Zhang
ZCZhifei Cao
Zhifei Cao
XXXingdong Xu
Xingdong Xu
ZHZihe Huo
Zihe Huo
QZQuansheng Zhou
Quansheng Zhou

23 November 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
JWJie Wang
Jie Wang
WXWei Xia
Wei Xia
YHYujie Huang
Yujie Huang
HLHaoran Li
Haoran Li
YTYuchen Tang
Yuchen Tang
JZJian Zhou
Jian Zhou
Background: Gastric cancer (GC) is one of the most lethal malignant tumors worldwide with poor outcomes. Vascular mimicry (VM) is an alternative blood supply to tumors that is independent of endothelial cells or angiogenesis. Previous studies have shown that VM was associated with poor prognosis in patients with GC, but the underlying mechanisms and the relationship between VM and immune infiltration of GC have not been well studied.Methods: In this study, expression profiles from VM-related genes were retrieved from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Cox regression was performed to identify key VM-related genes for survival. Subsequently, a novel risk score model in GC named VM index and a nomogram was constructed. In addition, the expression of one key VM-related gene (serpin family F member 1, SERPINF1) was validated in 33 GC tissues and 23 paracancer tissues using immunohistochemistry staining.Results: Univariate and multivariate Cox regression suggested that SERPINF1 and tissue factor pathway inhibitor 2 (TFPI2) were independent risk factors for the prognosis of patients with GC. The AUC (> 0.7) indicated the satisfactory discriminative ability of the nomogram. SsGESA and ESTIMATE showed that higher expression of SERPINF1 and TFPI2 is associated with immune infiltration of GC. Immunohistochemistry staining confirmed that the expression of SERPINF1 protein was significantly higher in GC tissues than that in paracancer tissues.Conclusion: A VM index and a nomogram were constructed and showed satisfactory predictive performance. In addition, VM was confirmed to be widely involved in immune infiltration, suggesting that VM could be a promising target in guiding immunotherapy. Taken together, we identified SERPINF1 and TFPI2 as immunologic and prognostic biomarkers related to VM in GC.

1 March 2016 in Biochemical Pharmacology
Verified
Journal Article
Closed access
BZBin Zhang
Bin Zhang
HHHongyan Han
Hongyan Han
SFShilong Fu
Shilong Fu
PYPing Yang
Ping Yang
ZGZhenlun Gu
Zhenlun Gu
ZCZhifei Cao
Zhifei Cao

1 September 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
WLWenming Liu
Wenming Liu
MMMei Meng
Mei Meng
BZBin Zhang
Bin Zhang
LDLongsheng Du
Longsheng Du
YPYanyan Pan
Yanyan Pan
ZCZhifei Cao
Zhifei Cao